Bethesda, Maryland 20892

  • Head and Neck Cancer


RATIONALE: Evaluating patients for eligibility in clinical trials may help doctors plan more effective surgery for patients who have cancer. PURPOSE: This screening trial is determining the eligibility of patients to participate in head and neck surgery clinical trials at the National Institute on Deafness and Other Communication Disorders and National Cancer Institute.

Study summary:

OBJECTIVES: - Evaluate eligibility of patients with neoplastic disease of the head and neck for clinical research protocols at the National Institute on Deafness and Other Communication Disorders Head and Neck Surgery Branch and National Cancer Institute. OUTLINE: Patients undergo various diagnostic procedures and clinical testing to determine protocol eligibility. The procedures and testing may include, but are not limited to, laboratory blood tests, including HLA typing, hepatitis screening, and HIV serology; various nuclear medicine and imaging scans with or without contrast dye; pulmonary function tests; endoscopy; incisional or excisional biopsy; fine-needle aspiration; and arteriogram. PROJECTED ACCRUAL: A maximum of 300 patients will be accrued for this study within 5 years.


DISEASE CHARACTERISTICS: - Histologically confirmed or suspected neoplastic disease of the head and neck with 1 of the following histological subtypes: - Squamous cell carcinoma - Verrucous carcinoma PATIENT CHARACTERISTICS: Age - Any age Performance status - Not specified Life expectancy - Not specified Hematopoietic - Not specified Hepatic - Not specified Renal - Not specified PRIOR CONCURRENT THERAPY: Biologic therapy - Not specified Chemotherapy - Concurrent chemotherapy allowed Endocrine therapy - Not specified Radiotherapy - Concurrent radiotherapy allowed Surgery - No concurrent surgical procedure except those required by a screening test or biopsy on this study



Primary Contact:

Study Chair
Carter Van Waes, MD, PhD
National Institute on Deafness and Other Communication Disorders (NIDCD)

Backup Contact:


Location Contact:

Bethesda, Maryland 20892
United States

Clinical Trials Office - Warren Grant Magnusen Clinical Center
Phone: 888-NCI-1937

Site Status: Recruiting

Data Source:

Date Processed: November 27, 2022

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on The form below is not enabled.